edaravone has been researched along with DDPAC in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone (EDR) is a free radical scavenger that is approved for motor neuron disease and acute ischemic stroke." | 5.62 | Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia. ( Bobrovskaya, L; Kelliny, S; Xiong, J; Zhou, XF, 2021) |
| "Edaravone (EDR) is a free radical scavenger that is approved for motor neuron disease and acute ischemic stroke." | 1.62 | Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia. ( Bobrovskaya, L; Kelliny, S; Xiong, J; Zhou, XF, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelliny, S | 1 |
| Xiong, J | 1 |
| Bobrovskaya, L | 1 |
| Zhou, XF | 1 |
1 other study available for edaravone and DDPAC
| Article | Year |
|---|---|
Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia.
Topics: Administration, Oral; Animals; Blotting, Western; Brain; Edaravone; Female; Frontotemporal Dementia; | 2021 |